Swedish
Program
| 10:30-10:40 | Juleen Zierath (Chairman JSC, KI) | Opening remarks |
| 10:45-11:15 | Karin Conde-Knape (Corporate Vice President, CVD Research, Novo Nordisk) | Opportunities and challenges in the development of treatments for NASH |
| 11:20-11:50 | Ulf Hedin (MMK, KI) | Unstable atherosclerosis - from patient to molecule to patient |
| 11:55-12:25 | Martin Ridderstråle (Vice President, Clinical Pharmacology, Novo Nordisk) | Translational Medicine at Novo Nordisk |
| Lunch break, sandwiches served outside Lecture hall | ||
| 13:20-13:50 | Peder Olofsson (MedS, KI) | Neural control of inflammation |
| 13:55-14:25 | Stephen Malin (MedS, KI) | The immune response to dyslipidemia |
| 14:30-15:00 | Elisabet Stener-Victorin (FYFA, KI) | Transcriptional and epigenetic changes in fat and muscle in women with PCOS |
| Break, coffee served outside lecture hall | ||
| 15:30-15:50 | Lars Ketscher (FYFA, KI) | Exploring muscle-derived exosomes as mediators of inter-organ communication |
| 15:55-16:15 | Montserrat Visa (MMK, KI) | In vivo imaging of pancreatic β-cell [Ca2+]i dynamics to study functional β-cell adaptation processes over prediabetes stages |
| 16:20-16:30 | Karin Dahlman-Wright (Vice-President, KI) | Closing remarks |
Registration
Participation is free of charge and includes lunch sandwiches and coffee why we need your registration latest September 20th. Please email Arja Kants, Arja.Kants@ki.se, to confirm your participation and inform of any food restrictions.
Date:
27 sep 2018
Group audience:
Event type:
Location:
CMB Lecture hall, Berzelius väg 21
Geographic location: